09/4-7/2025

Portaria Hotel / Pilion

During 09/4-7/2025, at Portaria Hotel / Pilion, the Society for the Study of Dermatovenereologic and Allergic Diseases (S.S.D.A.D.) organized the 8th Panhellenic Conference “Dermatological diseases: Past, present and future”.

Greek Dermatologists attended the congress and visited IASIS PHARMA exhibition stand to get informed of 4 important IASIS Dermatological products:

• Isotroin^®/ Isotretinoin  (at the new & unique 30mg dosage) indicated for Severe forms of Acne that are resistant to treatment with systemically administered antibiotics and topical therapy. Isotroin® 30mg  is added to the range of the other Isotroin® strengths  (10mg, 20mg & 40mg).

• Combi^®,  a combination of fluprednidene (1mg) + miconazole (20mg) cream for the treatment of Inflammatory Dermatomycoses.

• Modiwart^®/Ιmiquimod (12,5mg/sachet),  an innovative modifier of the immune response system indicated for the treatment of: External Genital Warts, Superficial Basal Cell Carcinomas and Aktinic Keratoses.

• Mastiha var. Chia Cutaneous Regenerative Gel:

Active Ingredient: Each ml of gel contains 10% lyophilized resin of natural Chios mastic Pistacia lentiscus, excipients. Packaging 30ml.

Since 2015, Chios mastic gum, has been officially recognized by the European Medicines Agency (EMA) as a Herbal Medicine, with the indication: Skin Inflammation & Skin Wound Healing (cutaneous use).

It is used in minor skin inflammations and as an aid in the healing of microtraumas.